Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Naltrexone”

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT03851731
What this trial is testing

Evaluation of Intranasal Naltrexone and Naloxone

Who this might be right for
Opioid-use Disorder
National Institute on Drug Abuse (NIDA) 12
Post-approval studies (Phase 4)Study completedNCT00000438
What this trial is testing

Naltrexone Treatment for Alcoholism

Who this might be right for
Alcoholism
Johns Hopkins University 192
Post-approval studies (Phase 4)Ended earlyNCT04547985
What this trial is testing

Naltrexone Treatment for Prolonged Grief Disorder (PGD)

Who this might be right for
Prolonged Grief Disorder
Weill Medical College of Cornell University 9
Early research (Phase 1)Study completedNCT00614328
What this trial is testing

Combination of Naltrexone and Baclofen for Alcohol Dependence:A Pilot Study.

Who this might be right for
Alcohol Dependence
University of North Carolina, Chapel Hill 40
Large-scale testing (Phase 3)Study completedNCT01180647
What this trial is testing

Extended-Release Naltrexone for Opioid Relapse Prevention Following Release From Jail

Who this might be right for
Opiate Dependence
NYU Langone Health 48
Post-approval studies (Phase 4)Study completedNCT01453374
What this trial is testing

VIVITROL in the Prevention of Re-arrest and Re-incarceration

Who this might be right for
Opioid Dependence
Alkermes, Inc. 27
Very early researchStudy completedNCT05007561
What this trial is testing

Understanding How Opioids Affect the Experiential and Neural Signatures of Social Experiences

Who this might be right for
NaltrexonePlacebo
San Diego State University 217
Testing effectiveness (Phase 2)Study completedNCT02206490
What this trial is testing

Trial of Naltrexone and Dextromethorphan for Gulf War Illness

Who this might be right for
Gulf War Illness
East Carolina University 60
Post-approval studies (Phase 4)Study completedNCT01377168
What this trial is testing

Naltrexone for Medication Compliance Among HIV-infected Men With Alcohol Use Disorder

Who this might be right for
HIVAlcohol Use Disorder
Fred Hutchinson Cancer Center 159
Not applicableStudy completedNCT01677065
What this trial is testing

A Randomized, Two-way, Crossover Study to Estimate the Relative Bioavailability of a Controlled-release Formulation of Oxycodone (40 mg) With Sequestered Naltrexone Compared With Immediate-release Oxycodone Tablets (20 mg) in Healthy Volunteers

Who this might be right for
Healthy
Pfizer 14
Post-approval studies (Phase 4)Study completedNCT01673594
What this trial is testing

Prevention of Stimulant-Induced Euphoria With an Opioid Receptor Antagonist

Who this might be right for
ADHDStimulant-Induced Euphoria
Massachusetts General Hospital 37
Large-scale testing (Phase 3)Study completedNCT04502251
What this trial is testing

LDN and tDCS in Fibromyalgia

Who this might be right for
Fibromyalgia
Centro Universitario La Salle 92
Not applicableWithdrawnNCT03762798
What this trial is testing

Can The Bridge Transition Opiate Use Disorder Patients in Stable Recovery From Buprenorphine to Naltrexone

Who this might be right for
Substance Use DisordersSubstance AbuseSubstance Use+1 more
The Cleveland Clinic
Large-scale testing (Phase 3)Study completedNCT01227044
What this trial is testing

Reducing Heavy Drinking to Optimize HIV/AIDS Treatment and Prevention

Who this might be right for
Reduction in Heavy Drinking in Patients With HIV
Yale University 51
Post-approval studies (Phase 4)UnknownNCT04589130
What this trial is testing

Evaluating Contrave for Weight Maintenance in Adults With BMI >= 27 Kg/m2, After 6 Month Behaviour Modification Program.

Who this might be right for
Obesity
St. Joseph's Healthcare Hamilton 89
Testing effectiveness (Phase 2)Study completedNCT04409041
What this trial is testing

Oral Low-Dose Naltrexone for Lichen Planopilaris and Frontal Fibrosing Alopecia

Who this might be right for
Lichen PlanopilarisFrontal Fibrosing Alopecia
Washington University School of Medicine 43
Early research (Phase 1)Study completedNCT01746901
What this trial is testing

Characterize the Abuse Liability of ALO-02 in Healthy, Non-Dependent, Recreational Opioid Abusers

Who this might be right for
Healthy
Pfizer 81
Early research (Phase 1)Study completedNCT00733720
What this trial is testing

Buprenorphine Naltrexone-P1 A-Cocaine

Who this might be right for
Cocaine-related Disorders
National Institute on Drug Abuse (NIDA) 8
Large-scale testing (Phase 3)Study completedNCT00183196
What this trial is testing

Effectiveness of Gabapentin When Used With Naltrexone to Treat Alcohol Dependence Compared to Placebo and Naltrexone Alone

Who this might be right for
Alcohol Dependence
Medical University of South Carolina 150
Large-scale testing (Phase 3)Study completedNCT00501696
What this trial is testing

Placebo-Controlled, Crossover-Design Study of the Effects of Low Dose Naltrexone

Who this might be right for
Multiple Sclerosis
University of California, San Francisco 80
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation